» Articles » PMID: 39409900

Genotoxic and Anti-Migratory Effects of Camptothecin Combined with Celastrol or Resveratrol in Metastatic and Stem-like Cells of Colon Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Oct 16
PMID 39409900
Authors
Affiliations
Soon will be listed here.
Abstract

: Colorectal cancer is one of the leading and most lethal neoplasms. Standard chemotherapy is ineffective, especially in metastatic cancer, and does not target cancer stem cells. A promising approach to improve cancer treatment is the combination therapy of standard cytostatic drugs with natural compounds. Several plant-derived compounds have been proven to possess anticancer properties, including the induction of apoptosis and inhibition of cancer invasion. This study was focused on investigating in vitro the combination of camptothecin (CPT) with celastrol (CEL) or resveratrol (RSV) as a potential strategy to target metastatic (LOVO) and stem-like (LOVO/DX) colon cancer cells. : The genotoxic effects that drive cancer cells into death-inducing pathways and the ability to inhibit the migratory properties of cancer cells were evaluated. The γH2AX+ assay and Fast-Halo Assay (FHA) were used to evaluate genotoxic effects, the annexin-V apoptosis assay to rate the level of apoptosis, and the scratch test to assess antimigratory capacity. : The results showed that both combinations CPT-CEL and CPT-RSV improve general genotoxicity of CPT alone on metastatic cells and CSCs. However, the assessment of specific double-stranded breaks (DSBs) indicated a better efficacy of the CPT-CEL combination on LOVO cells and CPT-RSV in LOVO/DX cells. Interestingly, the combinations CPT-CEL and CPT-RSV did not improve the pro-apoptotic effect of CPT alone, with both LOVO and LOVO/DX cells suggesting activation of different cell death mechanisms. Furthermore, it was found that the combinations of CPT-CEL and CPT-RSV improve the inhibitory effect of camptothecin on cell migration. : These findings suggest the potential utility of combining camptothecin with celastrol or resveratrol in the treatment of colon cancer, including more aggressive forms of the disease. So far, no studies evaluating the effects of combinations of these compounds have been published in the available medical databases.

References
1.
Khaiwa N, Maarouf N, Darwish M, Alhamad D, Sebastian A, Hamad M . Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise. Eur J Med Chem. 2021; 223:113639. DOI: 10.1016/j.ejmech.2021.113639. View

2.
Rauf A, Imran M, Butt M, Nadeem M, Peters D, Mubarak M . Resveratrol as an anti-cancer agent: A review. Crit Rev Food Sci Nutr. 2016; 58(9):1428-1447. DOI: 10.1080/10408398.2016.1263597. View

3.
Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini M . Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes. Curr Drug Targets. 2020; 22(9):998-1009. DOI: 10.2174/1389450121999201117115717. View

4.
Clay D, Fox D . DNA Damage Responses during the Cell Cycle: Insights from Model Organisms and Beyond. Genes (Basel). 2021; 12(12). PMC: 8701014. DOI: 10.3390/genes12121882. View

5.
Pereira C, Duarte M, Silva P, Bento da Silva A, Duarte C, Cifuentes A . Polymethoxylated Flavones Target Cancer Stemness and Improve the Antiproliferative Effect of 5-Fluorouracil in a 3D Cell Model of Colorectal Cancer. Nutrients. 2019; 11(2). PMC: 6412836. DOI: 10.3390/nu11020326. View